Cargando…
Overcoming barriers to the use of metformin: patient and provider perspectives
BACKGROUND: Metformin is the first-line treatment for type 2 diabetes mellitus. Observational studies show lower rates of use than would be expected from clinical guidelines. OBJECTIVE: We undertook a qualitative study of barriers to metformin use from the patient and provider perspective. DESIGN: P...
Autores principales: | Flory, James H, Keating, Scott, Guelce, Dominique, Mushlin, Alvin I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709787/ https://www.ncbi.nlm.nih.gov/pubmed/31686787 http://dx.doi.org/10.2147/PPA.S211614 |
Ejemplares similares
-
Identifying prevalence and risk factors for metformin non-persistence: a retrospective cohort study using an electronic health record
por: Flory, James H, et al.
Publicado: (2018) -
Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes
por: Flory, James H., et al.
Publicado: (2020) -
Impact of New York State’s Health Home program on access to care among patients with diabetes
por: Mayer, Victoria, et al.
Publicado: (2021) -
Covid-19: an Imperative to Bridge the Gap Between Medicine And Public Health
por: Mushlin, Alvin I.
Publicado: (2020) -
Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative
por: Edgar, Babette S, et al.
Publicado: (2021)